The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)

Total 1-year cost of diffuse large B-cell lymphoma (DLBCL) beyond first line (1L) therapy: A retrospective cohort analysis.

Anna  Purdum

Employment - Kite, a Gilead company

Stock and Other Ownership Interests  - Biogen; Bristol-Myers Squibb; Gilead Sciences; Illumina; Kite, a Gilead company; Regeneron

Ryan  Tieu

Other Relationship - Partnership for Health Analytic Research, LLC

Sheila R.  Reddy

Employment - Partnership for Health Analytic Research

Research Funding - Kite, a Gilead company

Michael  Broder

Research Funding - Amgen (Inst)

Travel, Accommodations, Expenses - Genentech; Novartis

Other Relationship - Amgen; Bard Medical; Boston Scientific; Bristol-Myers Squibb; Celgene; Eisai; Genentech; Genomic Health; Helsinn Healthcare; Ipsen; Jazz Pharmaceuticals; Johnson & Johnson; Lilly; Novartis; Onconova Therapeutics; Otsuka; Shionogi